WallStreetZenWallStreetZen

NASDAQ: TRVN
Trevena Inc Stock

$0.57-0.01 (-1.72%)
Updated Feb 28, 2024
TRVN Price
$0.57
Fair Value Price
N/A
Market Cap
$8.65M
52 Week Low
$0.51
52 Week High
$3.28
P/E
-0.21x
P/B
2.44x
P/S
2.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.21M
Earnings
-$30.77M
Gross Margin
80.8%
Operating Margin
-878.02%
Profit Margin
-959.3%
Debt to Equity
11.72
Operating Cash Flow
-$38M
Beta
0.74
Next Earnings
Mar 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

TRVN Overview

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TRVN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TRVN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TRVN is good value based on its book value relative to its share price (2.44x), compared to the US Biotechnology industry average (6.14x)
P/B vs Industry Valuation
TRVN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TRVN due diligence checks available for Premium users.

Be the first to know about important TRVN news, forecast changes, insider trades & much more!

TRVN News

Valuation

TRVN fair value

Fair Value of TRVN stock based on Discounted Cash Flow (DCF)
Price
$0.57
Fair Value
$3.50
Undervalued by
83.73%
TRVN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TRVN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.21x
Industry
13.96x
Market
35.52x

TRVN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.44x
Industry
6.14x
TRVN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TRVN's financial health

Profit margin

Revenue
$180.0k
Net Income
-$7.9M
Profit Margin
-4,405.6%
TRVN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TRVN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$45.1M
Liabilities
$41.6M
Debt to equity
11.72
TRVN's short-term assets ($39.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TRVN's short-term assets ($39.48M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TRVN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TRVN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.9M
Investing
$0.0
Financing
$15.8M
TRVN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TRVN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TRVN$8.65M-1.89%-0.21x2.44x
APM$8.63M+1.52%-0.45x0.39x
PSTV$8.73M-0.52%-0.32x3.33x
EIGR$8.57M-0.33%-0.10x-5.34x
CVKD$8.78M+11.96%-0.53x1.00x

Trevena Stock FAQ

What is Trevena's quote symbol?

(NASDAQ: TRVN) Trevena trades on the NASDAQ under the ticker symbol TRVN. Trevena stock quotes can also be displayed as NASDAQ: TRVN.

If you're new to stock investing, here's how to buy Trevena stock.

What is the 52 week high and low for Trevena (NASDAQ: TRVN)?

(NASDAQ: TRVN) Trevena's 52-week high was $3.28, and its 52-week low was $0.51. It is currently -82.62% from its 52-week high and 12.2% from its 52-week low.

How much is Trevena stock worth today?

(NASDAQ: TRVN) Trevena currently has 15,172,929 outstanding shares. With Trevena stock trading at $0.57 per share, the total value of Trevena stock (market capitalization) is $8.65M.

Trevena stock was originally listed at a price of $162.50 in Jan 31, 2014. If you had invested in Trevena stock at $162.50, your return over the last 10 years would have been -99.65%, for an annualized return of -43.18% (not including any dividends or dividend reinvestments).

How much is Trevena's stock price per share?

(NASDAQ: TRVN) Trevena stock price per share is $0.57 today (as of Feb 28, 2024).

What is Trevena's Market Cap?

(NASDAQ: TRVN) Trevena's market cap is $8.65M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Trevena's market cap is calculated by multiplying TRVN's current stock price of $0.57 by TRVN's total outstanding shares of 15,172,929.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.